Dongbao Li
-
- Cancer, Lipids, and Metabolism 3
- Internal Medicine top 10%
-
- Acute Myocardial Infarction Research 6
-
- Inflammatory Biomarkers in Disease Prognosis 4
-
- RNA modifications and cancer 5
- RNA Research and Splicing 3
- Extracellular vesicles in disease 2
-
- Coronary Interventions and Diagnostics 4
-
- Cardiac Imaging and Diagnostics 2
- Co-authors
- Qi HuaAnqi DongJiaoyang YangGege ShuZhi LiuWeikang LiChao DongJin Zhou
- Partner nations
- ChinaUnited States
In The Last Decade
Dongbao Li
25 papers receiving 557 citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Cancer Research 150
- Internal Medicine 36
- Cardiology and Cardiovascular Medicine 133
- Pulmonary and Respiratory Medicine 189
- Oncology 156
Countries citing papers authored by Dongbao Li
This map shows the geographic impact of Dongbao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongbao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongbao Li more than expected).
Fields of papers citing papers by Dongbao Li
This network shows the impact of papers produced by Dongbao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongbao Li. The network helps show where Dongbao Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dongbao Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2025 | 1 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 22 | |
| 8 | 2023 | 13 | |
| 9 | CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1breakdown → | 2022 | 192 |
| 10 | 2021 | 7 | |
| 11 | 2021 | 9 | |
| 12 | 2020 | 0 | |
| 13 | 2018 | 1 | |
| 14 | 2016 | 3 | |
| 15 | 2016 | 32 | |
| 16 | Associations between human aldosterone synthase CYP11B2 (-344T/C) gene polymorphism and antihypertensive response to valsartan in Chinese patients with essential hypertension. | 2015 | 14 |
| 17 | 2014 | 29 | |
| 18 | 2013 | 5 | |
| 19 | 2011 | 23 | |
| 20 | 2010 | 61 |
About Dongbao Li
Dongbao Li is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 28 papers that have together received 562 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (6 papers), RNA modifications and cancer (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers), Coronary Interventions and Diagnostics (4 papers), Cancer, Lipids, and Metabolism (3 papers), RNA Research and Splicing (3 papers), Extracellular vesicles in disease (2 papers) and Cardiac Imaging and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (150 citations), Internal Medicine (36 citations) and Cardiology and Cardiovascular Medicine (133 citations). Dongbao Li has collaborated with scholars based in China and United States. Frequent co-authors include Qi Hua, Anqi Dong, Jiaoyang Yang, Gege Shu, Zhi Liu, Weikang Li, Chao Dong, Jin Zhou, Yuhong Wang and Lin Hu. Their work appears in journals such as Oncogene, British Journal of Cancer and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.